At a glance
ClinicalIndex Comparison RecordN/ACompleted· 295 enrolled
Drug / intervention
Princess Filler Lidocainedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Subject- and Evaluating Investigator-blinded, Controlled, Multicenter, Split-face, Comparison Clinical Investigation to Evaluate Effectiveness and Safety of Princess FILLER Lidocaine in the Correction of Nasolabial Folds
In Brief
A clinical study evaluating Princess Filler Lidocaine for Dermatological Non-Disease. Completed, enrolled 295 participants across 11 sites.
Detailed Summary
Clinical Investigation to demonstrate the effectiveness and safety of Princess Filler Lidocaine in the correction of moderate to severe nasolabial folds
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDermatological Non-Disease
CountriesUnited States
CollaboratorsSyneos Health
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartJun 2019
First PostedJun 2019
Primary CompletionMay 2020
Study CompletionFeb 2022
TodayJul 2026
First PostedJun 19, 2019
Enrollment StartJun 4, 2019
Primary CompletionMay 29, 2020
Study CompletionFeb 15, 2022
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 7.0 years ago
Interventions
Princess Filler Lidocainedevice
correction of nasolabial folds